For the latest openings visit the Careers section of our website    CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza
For the latest openings visit the Careers section of our website    CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza

News & Events

  • CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza Read More >>

Risk Management Policy

The objective of the risk management policy document is to ensure that the company has proper and continuous risk identification and management process.

Counterfeit Drugs : In case of any information on /or availability of counterfeit products...Read More © 2017 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals